Sirona Biochem Corp

Defence Therapeutics Inc., headquartered in Vancouver, BC, is a leading biotechnology company focused on advancing drug delivery technologies to combat cancer and infectious diseases. Their innovative Accum Technology provides a scalable delivery platform that enhances drug efficacy by targeting infected cells with a tenfold impact compared to existing solutions. Committed to redefining treatment methodologies, Defence Therapeutics is pioneering novel cancer therapeutics and vaccine developments through proprietary platforms aimed at enhancing drug delivery across various diseases. With significant market potential and a robust collaborative framework, the company is positioned at the forefront of transformative biopharmaceutical innovations. Generated from the website

KOP Therapeutics is a Canadian biotech company based in Vancouver, BC, dedicated to developing affordable, non-toxic mRNA cancer therapies aimed at inducing cancer cell death with minimal side effects. The company holds an exclusive worldwide license from Thomas Jefferson University and has relocated its research operations to streamline the development process. Focused on targeted immunotherapy, KOP Therapeutics utilizes a novel AI-enabled drug design platform that selectively targets cancer cells while sparing healthy cells. Their flagship product, KOP101, aims to silence critical cancer genes, thereby preventing tumor growth and recurrence, with promising applications across various cancer types. Generated from the website

BioHarvest Sciences Inc., based in Vancouver, BC, is a pioneering company in the field of biologics, specializing in the development and manufacturing of patentable plant-based small complex molecules through its proprietary Botanical Synthesis technology. The company addresses the growing demand for natural and sustainable health solutions, offering innovative products in the nutraceutical, pharmaceutical, and cosmeceutical sectors. Founded by Dr. Yochi Hagay and Dr. Zaki Rakib in 2007, BioHarvest has achieved significant commercial success with its flagship product, VINIA, a red grape cell-based composition that enhances nitric oxide production and improves blood circulation. With a commitment to sustainability and environmental stewardship, BioHarvest is well-positioned to meet the industry's need for clean, consistent, and novel health ingredients. Generated from the website